Non-Motor Aspects of Parkinson's Disease
Web Chat with Dr. Kristin Appleby
Monday, April 23, 2012
Parkinson’s disease and/or its treatment can cause non-motor symptoms including mental disturbances, such as hallucinations, delusions and paranoia. For most patients, these mental disturbances can be controlled by changing their Parkinson’s treatment from one medicine to another, or treating patients with anti-psychotic medicines.
Kristin Appleby, MD, is a staff neurologist in the Center for Neurological Restoration at Cleveland Clinic’s Medina Hospital and Main Campus. She is board certified in neurology. Dr. Appleby completed her fellowship in movement disorders and residency in neurology at Georgetown University, in Washington, DC. She completed her internship in medicine at Washington Hospital, in Washington, DC, after receiving her medical degree at Georgetown University School of Medicine, in Washington, DC. Dr. Appleby has many specialty interests including Parkinson’s disease, dystonia, essential tremor and movement disorders.
View the complete Non-Motor Aspects of Parkinson's Disease web chat transcript below.
Medication Side Effects and Complications for Parkinson's Patients
Web Chat with Dr. Joseph Rudolph
Monday, April 23, 2012
Parkinson's disease is a chronic progressive neurological disease that affects nerve cells (neurons) in an area of the brain near the neck, known as the substantia nigra. These cells normally produce dopamine, a chemical (neurotransmitter) that transmits signals between areas in the brain. These signals, when working normally, coordinate smooth and balanced muscle movement.
Dr. Rudolph and the Center for Neurological Restoration at Cleveland Clinic offer expertise in the latest treatments for Parkinson’s disease and other movement disorders to help people improve function and quality of life. There have been rapid and remarkable changes over the past decade in treating Parkinson’s disease. The development of new medicines and an understanding of how best to use them and has significantly improved the quality of life for people with the disease.
View the complete Medication Side Effects and Complications for Parkinson's Patients web chat transcript below.
Parkinson's Disease Management & Treatment Options
Web Chat with Dr. Michal Gostkowski, DO
Tuesday, October 4, 2011
Approximately 1 million Americans have Parkinson's disease. More than 50,000 Americans are diagnosed with Parkinson's disease each year. Men after the age of 60 are more likely to develop the disease than women. The average age at the onset of symptoms is 60. However, 10 percent of patients are diagnosed before age 40. There is increasing evidence that Parkinson's disease may be inherited.
Dr. Michal Gostkowski and the physicians in the Center for Neurological Restoration at Cleveland Clinic offer expertise in the latest treatments for Parkinson’s disease and other movement disorders to help people improve function and quality of life. Common treatment options include medication, therapy, and surgical management.
View the complete Parkinson's Disease Management & Treatment Options web chat transcript below.
Parkinson's Disease and Other Movement Disorders
Web Chat with Dr. Hubert Fernandez, MD
Friday, October 29, 2010
Many movement disorders are inherited, while the causes of others may be attributed to injuries, autoimmune diseases, infections and certain medications, or simply unknown. The most common types of movement disorders include: restless legs syndrome, Tourette’s syndrome, Parkinson’s disease, dystonia, essential tremor, tics and dyskinesias. Incidence rates and demographics vary for different types of movement disorders.
Dr. Fernandez and the Center for Neurological Restoration at Cleveland Clinic physicians offer expertise and the total “team approach” in delivering the latest treatments for movement disorders to help people improve function and quality of life. Common treatment options include medications, therapy and surgical management.
View the complete Parkinson's Disease & Other Movement Disorders web chat transcript below.
Managing Parkinson's Disease and Other Movement Disorders
Web Chat with Dr. Andre Machado, MD, PhD and Dr. Anwar Ahmed, MD
Monday, September 14, 2009
Parkinson’s disease is a chronic, progressive neurological disorder that affects a small area of nerve cells deep within the brain. Approximately 1.5 million Americans have Parkinson’s disease, including one out of every 100 people over the age of 60.
Andre Machado, MD, PhD, is the director of the Center for Neurological Restoration and associate staff in the department of neurosciences, the department of biomedical engineering and department of neurological surgery, all located on Cleveland Clinic’s main campus. He earned a doctorate in medicine and a PhD in experimental neurology from the University of Sao Paulo in Sao Paulo, Brazil. He then completed a neurology internship and residency at the same institution. Dr. Machado also completed a fellowship at Cleveland Clinic in stereotactic and functional neurosurgery and was co-investigator of a NIH study to assess the safety of using MRIs for deep brain stimulation.
Anwar Ahmed, MD is a neurologist and a staff member of Cleveland Clinic’s Center for Neurological Restoration. He specializes in movement disorders, tremor analysis, Parkinson’s disease and related neurodegenerative disorders, dystonia and botulinum toxin injection for dystonia, and deep brain stimulation for movement disorders.
View the complete Managing Parkinson's Disease & Other Movement Disorders web chat transcript below.
Bicycling to Treat Parkinson's Disease
Biomedical engineer Jay Alberts, PhD, Assistant Professor at Cleveland Clinic Lerner Research Institute, is featured in NBC's Kevin Tibbles' report, elaborating on the implications of his study of Parkinson's disease and forced exercise.
Power Pedaling: New Hope for Parkinson's Patients
Biomedical engineer Jay Alberts, PhD, Assistant Professor at Cleveland Clinic Lerner Research Institute, is featured on ABC's “Good Morning America,” speaking on how forced exercise improved motor function in bicyclists with Parkinson's disease.